ALCON LABORATORIES INDIA PVT. LTD

To advertise here email us on [email protected]


Contact Information
Company Name ALCON LABORATORIES INDIA PVT. LTD
Contact Person
Address Unit No: 502, Tower "D", 5th Floor, RMZ Infinity, Benniganahalli, Old Madras Road, Bangalore.
Bangalore, Karnataka, India.
Zip / Postal Code 560 016
Telephone 91+80-4006, 4600
Fax
Email Click here to email us
Website www.alcon.com
Description ABOUT US:
We challenge ourselves to meet Alcon's mission every day – to enhance, preserve and restore vision worldwide. Alcon employees, around the globe, go a step beyond that mission and dedicate themselves to making Alcon the most respected and trusted eye care company in the world. We know we are earning our position as the first choice in eye care products every day through hard work and dedication – we never take that for granted.
PRODUCTS:

Pharmaceutical:
Alcon is the largest ophthalmic pharmaceutical company in the world. Our pharmaceuticals are used globally every day to treat millions of people who suffer from eye diseases and conditions such as glaucoma, eye infection, eye inflammation, eye allergies and ear infections. We've highlighted some of our flagship pharmaceutical products that are revolutionizing eye care and eye health.
Eye Allergies:
Eye allergies, also known as allergic conjunctivitis, often result in red, swollen, itchy eyes that create a range of annoyances from mild to severe. These allergies can be caused by a number of situational or environmental factors – animal hair and dander, and pollen from trees, grass and other plants.
PATADAY™:
Ophthalmic Solution
PATADAY™:
(olopatadine hydrochloride) 0.2%, is Alcon's newest prescription allergy eye drop and is known in some markets as PATANOL® S solution. With twice the concentration of PATANOL® solution, it is the first eye drop approved for once-a-day dosing for ocular itching associated with allergic conjunctivitis.

Wait 10 minutes after using PATADAY™ solution before inserting contact lenses. Patients should not touch the bottle tip to any surface to avoid the risk of contamination.

This product should not be taken by patients with a sensitivity or allergy to its ingredients. Safety and efficacy have not been determined in children under age three. Caution should be used when administering this drug to pregnant or nursing women. The most common side effect of PATADAY™ solution is headache, but patients may also experience blurred vision, burning, stinging or nausea, as well as other effects. Some of these events may be related to the underlying condition itself and not therapy. If you experience any of these symptoms contact your doctor. For full U.S. prescribing information, see the product insert below.

For more information visit the U.S. Web site at www.pataday.com.


PATANOL® / OPATANOL® :
Ophthalmic Solution

PATANOL® ophthalmic solution (olopatadine hydrochloride ophthalmic solution) 0.1%, also known in many countries as OPATANOL® solution, is the world's leading prescription eye drop used to treat the signs and symptoms of allergic conjunctivitis including itching, redness, chemosis, tearing and lid swelling.

Wait 10 minutes after using PATANOL® solution before inserting contact lenses. Patients should not touch the bottle tip to any surface to avoid the risk of contamination.

This product should not be taken by patients with a sensitivity or allergy to its ingredients. Safety and efficacy have not been determined in children under age three. Caution should be used when administering this drug to pregnant or nursing women. The most common side effect of PATANOL® solution is a headache, but patients may also experience blurred vision, burning, stinging or nausea, as well as other effects. If you experience any of these symptoms contact your doctor. For full U.S. prescribing information, see the product insert below.
Eye Infections:
Eye infections can range from common ailments, such as pink eye or conjunctivitis, to serious and sight-threatening conditions. Causes can include bacteria, complications with contact lenses or complications with surgery and other eye trauma.


VIGAMOX®*:
Ophthalmic Solution

VIGAMOX® (moxifloxacin HCI ophthalmic solution) 0.5% as base, is an antibiotic used to treat the most common eye infection, bacterial conjunctivitis, commonly called "pink eye."

Do not wear contact lenses while using VIGAMOX® solution. Patients should not touch the bottle tip to any surface to avoid the risk of contamination.

This product should not be taken by patients with a sensitivity or allergy to its ingredients. Safety and efficacy have not been determined in children under age one. Caution should be used when administering this drug to pregnant or nursing women. The most common side effect of VIGAMOX® solution is decreased visual acuity, but patients may also experience burning or stinging, red or itchy eyes, or rash, as well as other effects. If you experience any of these symptoms contact your doctor. For full U.S. prescribing information, see the product insert below.

Eye Inflammation:
Eye inflammation most commonly occurs in response to eye surgery, which while necessary, can upset the delicate tissue of the eye. It can also occur as a result of infection.


NEVANAC® Ophthalmic Suspension
NEVANAC®:
(nepafenac ophthalmic suspension) 0.1% treats eye pain and inflammation resulting from cataract surgery.

Do not wear contact lenses while using NEVANAC® suspension. Patients should not touch the bottle tip to any surface to avoid the risk of contamination.

This product should not be taken by patients with a sensitivity or allergy to its ingredients. Safety and efficacy have not been determined in children under age 10. Caution should be used when administering this drug to pregnant or nursing women. This drug should not be used in late pregnancy. The most common side effects of NEVANAC® suspension include decreased visual acuity, a feeling that something is in the eye, increased eye pressure or a sticky sensation, as well as other effects. If you experience any of these symptoms contact your doctor. As with all NSAIDs, this drug may delay ocular healing and prolonged use may result in corneal problems. For full U.S. prescribing information, see the product insert below.

TRIESENCE®:
Ophthalmic Suspension

TRIESENCE® (triamcinoline acetonaide injectable suspension) 40 mg/ml is a preservative-free injectable suspension designed and approved for intraocular use in the United States, for treatment of uveitis, certain types of eye inflammation unresponsive to topical corticosteroids, sympathetic ophthalmia, and temporal arteritis. The drug is also approved for use in assisting with visualization of the retina during surgery. For more information on surgical indications, see surgical products.

Triesence® suspension is contraindicated in patients with systemic fungal infection and those with hypersensitivity to triamcinolone or any component of this product. Ophthalmic side effects may include cataracts, infections, and glaucoma.

TOBRADEX®:
Ophthalmic Suspension

TOBRADEX® (tobramycin and dexamethasone) sterile ophthalmic suspension and ointment have been the most frequently prescribed anti-infective and anti-inflammatory combination drug on the market for 20 years. TOBRADEX® suspension is used to treat eye inflammation where infection or the risk of infection is present.

Do not wear contact lenses while using TOBRADEX® suspension. Patients should not touch the bottle tip to any surface to avoid the risk of contamination.

This product should not be taken by patients with a sensitivity or allergy to its ingredients or by persons with viral or fungal infections of the eye. Safety and efficacy have not been determined in children under age two. Caution should be used when administering this drug to pregnant or nursing women. The most common side effects of TOBRADEX® suspension are lid itching and swelling, but patients may also experience elevated intraocular pressure (IOP) and delayed wound healing, as well as other effects. If you experience any of these symptoms contact your doctor. Prolonged use of this drug may result in a higher likelihood of fungal infection or secondary bacterial infection. For full U.S. prescribing information, see the product insert below.

Ear Infection
Outer ear infections, scientifically referred to as otitis externa, are fairly common bacterial infections. Although the presence of bacteria in the outer ear canal is normal and healthy, it can develop into infection when the right conditions are present for it to thrive. Such conditions include when skin in the ear canal is injured or damaged, often from objects like cotton swabs, or when water gets trapped in the ear from activities like swimming. The infection creates swelling, which is often painful. Middle ear infections can develop as a result of colds or flu, when bacteria move into the middle ear from the nose or throat.


CIPRODEX®*:
Otic Suspension

CIPRODEX® (ciprofloxacin 0.3% and dexamethasone 0.1%) is the only otic combination therapy that combines a steroid with a fluoroquinolone antibiotic, to reduce swelling and fight infection in both the middle and outer ear.

Patients should try to keep the treated area dry and clean and should avoid getting the infected ear wet. Patients should not touch the bottle tip to any surface including the hand to avoid the risk of contamination.

This product should not be taken by patients with a sensitivity or allergy to ciprofloxacin or any other of its ingredients. Safety and efficacy have not been determined in children under six months of age. Caution should be used when administering this drug to pregnant or nursing women. The most common side effect of CIPRODEX® otic is ear discomfort. Other common side effects include itching of the ear and ear debris, as well as other effects. If you experience any of these symptoms contact your doctor. For full U.S. prescribing information, see the product insert below.
* Licensed to Alcon, Inc. by Bayer Schering Pharma AG. CIPRODEX is a registered trademark of Bayer AG, licensed to Alcon, Inc. by Bayer AG.


Glaucoma:

Glaucoma is a leading cause of blindness, which usually occurs as a result of elevated intraocular pressure (IOP). Glaucoma is a disease without noticeable symptoms. Consequently it may be diagnosed late and patient compliance with treatment may be poor. Glaucoma can easily be detected early, however, through a standard eye exam before there is any loss of vision. Today there are convenient treatments that can lower intraocular pressure (IOP).

TRAVATAN Z®:
Ophthalmic Solution

TRAVATAN Z® (travoprost ophthalmic solution) 0.004% is used to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who may be intolerant to other intraocular pressure lowering medications or for whom other medications do not sufficiently lower IOP. TRAVATAN Z® solution is our most recent formulation that replaces benzalkonium chloride (BAK) with SOFZIA®, an ionic buffered preservative system.


TRAVATAN Z® solution should not be administered while wearing contact lenses. Patients should not touch the bottle tip to any surface to avoid the risk of contamination.

This product should not be taken by those with a sensitivity or allergy to its ingredients. Safety and efficacy have not been determined in children. Caution should be used when administering this drug to pregnant or nursing women. The most common side effect of TRAVATAN Z® solution is red eyes, but patients may also experience decreased visual acuity, eye pain and blurred vision, as well as other effects. If you experience any of these symptoms contact your doctor. Prostaglandins, such as TRAVATAN Z® solution, have been known to cause changes in eye color and eye lid skin color, as well as changes in eye lashes, which may be permanent. For full U.S. prescribing information, see the product insert below.

U.S. Product Insert
TRAVATAN Z® Ophthalmic Solution [PDF]

TRAVATAN® :
Ophthalmic Solution

TRAVATAN® solution (travoprost ophthalmic solution) 0.004% is used to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who may be intolerant to other intraocular pressure lowering medications or for whom other medications do not sufficiently lower IOP.

TRAVATAN® solution should not be administered while wearing contact lenses. Patients should not touch the bottle tip to any surface to avoid the risk of contamination.

This product should not be taken by those with a sensitivity or allergy to its ingredients. Safety and efficacy have not been determined in children. Caution should be used when administering this drug to pregnant or nursing women. The most common side effect of TRAVATAN® solution is red eyes, but patients may also experience decreased visual acuity, eye pain and blurred vision, as well as other effects. If you experience any of these symptoms contact your doctor. Prostaglandins, such as TRAVATAN® solution, have been known to cause changes in eye color and eye lid skin color, as well as changes in eye lashes, which may be permanent. For full U.S. prescribing information, see the product insert below.


AZARGA® :
Ophthalmic Suspension

AZARGA® (5 mg/ml +10 mg/ml eye drops, suspension) is not available in the United States. AZARGA® suspension is indicated for the decrease of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction.

This product should not be taken by those with a sensitivity or allergy to its ingredients, in patients with heart failure or disorders of heart rhythm, respiratory problems, or severe kidney disease. Safety and efficacy have not been determined in children. Caution should be used when administering this drug to pregnant women. The most common side effect of AZARGA® suspension is blurred vision.


DUOTRAV® Solution

DUOTRAV® :
(40 micrograms/ml +5 mg/ml eye drops, solution) is not available in the United States. DUOTRAV® solution combines two ocular hypertension reduction agents in one bottle. As they work together, DUOTRAV® solution decreases intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who are insufficiently responsive to topical beta blockers or prostaglandins.

DUOTRAV® solution should not be administered while wearing contact lenses. Patients should not touch the bottle tip to any surface to avoid the risk of contamination.

This product should not be taken by those with a sensitivity or allergy to its ingredients. Safety and efficacy have not been determined in children. Caution should be used when administering this drug to pregnant or nursing women. The most common side effect of DUOTRAV® solution is red eyes, but patients may also experience decreased visual acuity, eye pain and blurred vision, as well as other effects. If you experience any of these symptoms contact your doctor.


AZOPT® :
Ophthalmic Suspension

AZOPT® (brinzolamide ophthalmic suspension) 1% is used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

AZOPT® suspension should not be administered while wearing contact lenses. Patients should not touch the bottle tip to any surface to avoid the risk of contamination.

This product should not be taken by those with a sensitivity or allergy to its ingredients. Safety and efficacy have not been determined in children. Caution should be used when administering this drug to pregnant or nursing women. The most common side effects of AZOPT® suspension are blurred vision and bitter, sour or unusual taste. If you experience any of these symptoms contact your doctor. For full U.S. prescribing information, see the product insert below.
Last Updated: 2010-01-04 00:57:01  
See something wrong?Please mail to [email protected]
Go Back
Categorys listing
The company ' ALCON LABORATORIES INDIA PVT. LTD ' is listed in our Yellow Pages section in the following Categories and Sub Categories.
Pharmaceuticals
Pharmaceuticals - Manufacturers